"At this stage, I would say no: this is a highly, highly experimental procedure," he says, noting that gains from deep brain stimulation, using implantable pacemaker-like devices to shock the brain, but which weren't available when his project started, generally show better results.

But Dr. Eidelberg isn't completely ruling the nerve-tissue transplant therapy out.


"The studies are promising, although the results are not optimal," he says. "But it's not a taboo subject to continue. These people did OK."

Back to HCB News

More Industry Headlines